Change of temperature in mouse tumour tissue immersed in a water bath at 44°C

Oncology Reports

Volumn 5, Issue 5, 1998, Pages 1061-1064

  Imamura, Masato ^a   Seki, Toshihito ^a   Tamai, Toru ^a   Kunieda, Kouji ^a   Nakatani, Sei ^a   Yamashiki, Noriyo ^a   Nishimura, Akira ^a   Nakagawa, Taiichi ^a   Inoue, Kyoichi ^a   Imamura, Masahiro ^a   Nagata, Kenji ^a   Kasahara, Mika ^a   Okamura, Akiharu ^a   Harada, Kazuki ^b  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b HEALTH RESEARCH FOUNDATION   (Japan)

Author keywords

DdY mouse; Hyperthermia; Multi thermocouple thermosensor; Sarcoma 180

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HINDLIMB; HYPERTHERMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA; TEMPERATURE SENSITIVITY; THERMORECEPTOR; WATER IMMERSION;

ANIMALS; BODY TEMPERATURE; EQUIPMENT DESIGN; HINDLIMB; HYPERTHERMIA, INDUCED; MICE; MUSCLE, SKELETAL; SARCOMA 180; THERMOMETERS; TIME FACTORS;

EID: 13144250138     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Kunieda K, Seki T, Nakatani S, Wakabayashi M, Shiro T, Inoue K, Sougawa M, Kimura R and Harada K: Implantation treatment method of slow release anticancer doxorubicin containing hydroxyapatite (DOX-HAP) complex. A basic study of a new treatment for hepatic cancer. Br J Cancer 67: 668-673, 1993.
2. Imamura M, Seki T, Kunieda K, Nakatani S, Inoue K, Nakano T and Harada K: Hydroxyapatite beads containing doxorubicin hydrochloride (DOX) and buthionine sulfoximine (BSO); a new anticancer drug design for local treatment with multiple drugs. Oncol Rep 2: 33-36, 1995.
3. Imamura M, Seki T, Kunieda K, Wakabayashi M, Inoue K, Obiya Y and Harada K: Antitumor effect of doxorubicin hydrochloride (DOX) and buthionine sulfoximine (BSO)-hydroxyapatite (HAP) complex on transplanted tumors in vivo. Oncol Rep 2: 509-511, 1995.
4. Imamura M, Seki T, Kunieda K, Nakatani S, Tamai T, Inoue K, Imamura M, Nagata K, Tanaka Y, Obiya Y and Harada K: Potential applicability of clinical hyperthermia using a Thermotron-RF8 as assessed from thermal distribution in an agar phantom containing hydroxyapatite. Oncol Rep 3: 1017-1019, 1996.
5. Imamura M, Seki T, Kunieda K, Tamai T, Nishimura A, Inoue K and Harada K: Enhancement by hyperthermia of the in vivo antitumour effect of doxorubicin hydrochloride (DOX) and buthionine sulfoximine (BSO)-hydroxyapatite (HAP) complex. Int J Oncol 10: 961-964, 1997.
6. Imamura M, Seki T, Kunieda K, Tamai T, Nakagawa T, Shiro T, Inoue K and Harada K: New material on drug delivery system (DDS) combined with hyperthermia targeting liver cancer. In: Proceedings of KSP and CRS Joint Symposium on Recent Advances in Drug Delivery and Biomaterials. Jeong SY and Park K (eds). pp690-693, 1997.
7. Imamura M, Harada K, Imamura M, Akagi K and Tanaka Y: Presumption of mechanism of intracellular molecular damage on procaryote using acid heating. In: Hyperthermic Oncology in Japan '94. Tanaka Y (ed). Koseisha Co., Ltd., Osaka, pp268-269, 1995.
8. Marmor JB, Hahn N and Hahn GM: Tumor cure and cell survival after localized radiofrequency heating. Cancer Res 37: 879-883, 1977.
9. Calderwood SK and Dickson JA: Effect of hyperglycemia on blood flow, pH, and response to hyperthermia (42°) of the Yoshida sarcoma in the rat. Cancer Res 40: 4728-4733, 1980.
10. Jain RK, Shah SA and Finney PL: Continuous noninvasive monitoring of pH and temperature in rat Walker 256 carcinoma during normoglycemia and hyperglycemia. J Natl Cancer Inst 73: 429-436, 1984.
11. Nikawa Y, Kikuchi M, Terakawa T and Matsuda T: Heating system with a lens applicator for 430 MHz microwave hyperthermia. Int J Hyperthermia 6: 671-684, 1990.